After a 96% 1-Year Run, This Director Sold 37,600 PHVS Shares for $1.3 Million. Is the Rally Over?
This late-stage biotech innovator in rare disease therapies reported significant insider selling amid strong one-year share price gains.
Overview
Johannes Gerardus Christiaan Petrus Schikan, Director, reported the sale of 37,600 shares of Pharvaris N.V. (NASDAQ:PHVS) in open-market transactions valued at approximately $1.33 million, according to a SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average purchase price ($35.41); post-transaction value based on June 30, 2026, market close ($34.58).
* 1-year performance calculated using June 30th, 2026 as the reference date.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.